Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Nov 6;25(21):5175.
doi: 10.3390/molecules25215175.

Arthropod-Borne Disease Control at a Glance: What's New on Drug Development?

Giovanni Benelli  1 , Riccardo Petrelli  2 , Angelo Canale  1
Affiliations
Editorial

Arthropod-Borne Disease Control at a Glance: What's New on Drug Development?

Giovanni Benelli et al. Molecules. .

Abstract

Discovering and validating effective drugs to manage arthropod-borne diseases (ABD) is a timely and important research challenge with major impacts on real-world control programs at the time of quick resistance development in the targeted pathogens. This editorial highlights major research advances in the development of drugs for the control of vector-borne diseases, with a significant focus on malaria, Chagas disease, dengue, human African trypanosomiasis, leishmaniasis, and Zika. Broad reviews providing new insights on ABD recently published in Molecules have also been covered in "The Editors' pick" section.

Keywords: Chagas disease; Japanese encephalitis; West Nile fever; Zika virus; chikungunya; dengue; human African trypanosomiasis; leishmaniasis; lymphatic filariasis; malaria; yellow fever.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. World Health Organization Vector Borne Diseases. [(accessed on 29 October 2020)];2020 Available online: https://www.who.int/news-room/fact-sheets/detail/vector-borne-diseases.
    1. Miglianico M., Eldering M., Slater H., Ferguson N., Ambrose P., Lees R.S., Koolen K.M.J., Pruzinova K., Jancarova M., Volf P., et al. Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases. Proc. Natl. Acad. Sci. USA. 2018;115:E6920–E6926. doi: 10.1073/pnas.1801338115. - DOI - PMC - PubMed
    1. Kim K.S. Current challenges in the development of vaccines and drugs against emerging vector-borne diseases. Curr. Med. Chem. 2019;26:2974–2986. doi: 10.2174/0929867325666181105121146. - DOI - PubMed
    1. Benelli G., Maggi F., Petrelli R., Canale A., Nicoletti M., Rakotosaona R., Rasoanaivo P. Not ordinary antimalarial drugs: Madagascar plant decoctions potentiating the chloroquine action against Plasmodium parasites. Ind. Crops Prod. 2017;103:19–38. doi: 10.1016/j.indcrop.2017.03.032. - DOI
    1. Ashley E.A., Dhorda M., Fairhurst R.M., Amaratunga C., Lim P., Suon S., Sreng S., Anderson J.M., Mao S., Sam B., et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2014;371:411–423. doi: 10.1056/NEJMoa1314981. - DOI - PMC - PubMed

Publication types

LinkOut - more resources